Wells Fargo Maintains Equal-Weight on Nevro, Lowers Price Target to $27
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Lawrence Biegelsen maintains an Equal-Weight rating on Nevro (NYSE:NVRO) and lowers the price target from $37 to $27.
June 06, 2023 | 11:44 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Wells Fargo maintains an Equal-Weight rating on Nevro and lowers the price target from $37 to $27.
The news directly mentions Nevro and the lowered price target by Wells Fargo. This may cause some short-term uncertainty among investors, but the Equal-Weight rating suggests that the stock is still considered fairly valued. Therefore, the short-term impact on the stock price is neutral.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100